Taxonogenomics Description of Parabacteroides Timonensis Sp. Nov
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Macellibacteroides Fermentans Gen. Nov., Sp. Nov., a Member of the Family Porphyromonadaceae Isolated from an Upflow Anaerobic Filter Treating Abattoir Wastewaters
International Journal of Systematic and Evolutionary Microbiology (2012), 62, 2522–2527 DOI 10.1099/ijs.0.032508-0 Macellibacteroides fermentans gen. nov., sp. nov., a member of the family Porphyromonadaceae isolated from an upflow anaerobic filter treating abattoir wastewaters Linda Jabari,1,2 Hana Gannoun,2 Jean-Luc Cayol,1 Abdeljabbar Hedi,1 Mitsuo Sakamoto,3 Enevold Falsen,4 Moriya Ohkuma,3 Moktar Hamdi,2 Guy Fauque,1 Bernard Ollivier1 and Marie-Laure Fardeau1 Correspondence 1Aix-Marseille Universite´ du Sud Toulon-Var, CNRS/INSU, IRD, MIO, UM 110, Case 925, Marie-Laure Fardeau 163 Avenue de Luminy, 13288 Marseille Cedex 9, France [email protected] 2Laboratoire d’Ecologie et de Technologie Microbienne, Institut National des Sciences Applique´es et de Technologie, Centre Urbain Nord, BP 676, 1080 Tunis Cedex, Tunisia 3Microbe Division/Japan Collection of Microorganisms, RIKEN BioResource Center 2-1 Hirosawa, Wako, Saitama 351-0198, Japan 4CCUG, Culture Collection, Department of Clinical Bacteriology, University of Go¨teborg, 41346 Go¨teborg, Sweden A novel obligately anaerobic, non-spore-forming, rod-shaped mesophilic bacterium, which stained Gram-positive but showed the typical cell wall structure of Gram-negative bacteria, was isolated from an upflow anaerobic filter treating abattoir wastewaters in Tunisia. The strain, designated LIND7HT, grew at 20–45 6C (optimum 35–40 6C) and at pH 5.0–8.5 (optimum pH 6.5–7.5). It did not require NaCl for growth, but was able to grow in the presence of up to 2 % NaCl. Sulfate, thiosulfate, elemental sulfur, sulfite, nitrate and nitrite were not used as terminal electron acceptors. -
Micromasters of the Earth
Micromasters of the Earth Anna WĘGRZYN – the Department of Environmental Biotechnology at the Faculty of Energy and Environmental Engineering at the Silesian University of Technology, Gliwice Please cite as: CHEMIK 2011, 65, 11, 1182-1189 Introduction membrane constitutes about 25% of the whole bacterium mass. It is estimated that our planet was formed about 4.6 billion Peptidoglycan (murein) is a fundamental substance of the bacterial cell years ago. At the very beginning, it was just a lifeless ball of melted wall. In their cell walls, bacteria can contain different quantities of murein magma. The Earth surface was gradually getting cool until reaching which is connected with a diversified sensitivity to dyes. Depending the temperature at which water and other chemical compounds on the number of peptidoglycan layers, the applied dyes (e.g. crystal could have been created. First traces of life are being discovered in violet) are retained inside the cell wall or leached from it. This is the rocks formed about 3.85 billion years ago. Stromatolites - biogenic basis for classifying bacteria into a group of Gram-positive or Gram- rocks dated at about 3.4 billion years which formation was connected negative bacteria (originating from the name of the Danish scientist with activities of cyanobacteria – autotrophic organisms being able to Gram who was the first person to perform the complex staining with XII Conference Environmental produce oxygen in the process of photosynthesis, constitute the fossil crystal violet in 1884). The cells of Gram-negative bacteria contain trace of the prokaryotic structure1 of primitive forms. The creation of lower quantities of murein than in case of Gram-positive bacteria. -
Antonie Van Leeuwenhoek Journal of Microbiology
Antonie van Leeuwenhoek Journal of Microbiology Kroppenstedtia pulmonis sp. nov. and Kroppenstedtia sanguinis sp. nov., isolated from human patients --Manuscript Draft-- Manuscript Number: ANTO-D-15-00548R1 Full Title: Kroppenstedtia pulmonis sp. nov. and Kroppenstedtia sanguinis sp. nov., isolated from human patients Article Type: Original Article Keywords: Kroppenstedtia species, Kroppenstedtia pulmonis, Kroppenstedtia sanguinis, polyphasic taxonomy, 16S rRNA gene, thermoactinomycetes Corresponding Author: Melissa E Bell, MS Centers for Disease Control and Prevention Atlanta, Georgia UNITED STATES Corresponding Author Secondary Information: Corresponding Author's Institution: Centers for Disease Control and Prevention Corresponding Author's Secondary Institution: First Author: Melissa E Bell, MS First Author Secondary Information: Order of Authors: Melissa E Bell, MS Brent A. Lasker, PhD Hans-Peter Klenk, PhD Lesley Hoyles, PhD Catherine Spröer Peter Schumann June Brown Order of Authors Secondary Information: Funding Information: Abstract: Three human clinical strains (W9323T, X0209T and X0394) isolated from lung biopsy, blood and cerebral spinal fluid, respectively, were characterized using a polyphasic taxonomic approach. Comparative analysis of the 16S rRNA gene sequences showed the three strains belonged to two novel branches within the genus Kroppenstedtia: 16S rRNA gene sequence analysis of W9323T showed closest sequence similarity to Kroppenstedtia eburnea JFMB-ATE T (95.3 %), Kroppenstedtia guangzhouensis GD02T (94.7 %) and strain X0209T (94.6 %); sequence analysis of strain X0209T showed closest sequence similarity to K. eburnea JFMB-ATE T (96.4 %) and K. guangzhouensis GD02T (96.0 %). Strains X0209T and X0394 were 99.9 % similar to each other by 16S rRNA gene sequence analysis. The DNA-DNA relatedness was 94.6 %, confirming that X0209T and X0394 belong to the same species. -
WO 2018/064165 A2 (.Pdf)
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. -
Aerobic Endospore Procedure
Office of Research and Development Photos Aerobic Endospore Procedure Laura A. Boczek Microbiologist US EPA – Office of Research and Development Aerobic Endospore Background Aerobic endospores are protective structures that some genera of bacteria have the ability to produce in response to a stressful environment. These genera are in general harmless to humans and are saprophytic organisms that are ubiquitous in many soil and water environments. These organisms can stay in the endospore form until conditions are favorable for them to germinate out of the endospore state to a vegetative state. This allows them to persist in their environment and resist many environmental stressors such as heat, desiccation, disinfection, and irradiation. 2 Aerobic Endospores Procedure Standard Methods 9218 A & B – outlines how to culture and measure aerobic endospores. Basic steps : 1. Obtaining a representative sample 2. Killing off any vegetative cells that could be in the sample by heat treatment 3. Using membrane filtration to concentrate endopsores in sample and then allow them to grow to enumerate Representative sample Samples should be collected using sterile wide mouth containers and care should be taken not to contaminate the samples during collection by using aseptic technique. Samples that contain a disinfectant residual such as chlorine should have sodium thiosulfate added to the sample bottle prior to collection in order to quench the chlorine. Samples should include a sufficient volume that can be processed to adequately determine treatment efficacy. • Sample waters will contain various amounts of endospores. Therefore if treatment efficacy is the reason why aerobic endospores are being measured a larger volume of sample may need to be collected and processed to determine efficacy. -
Chapter 20 the Proteobacteria
Fig. 20.21 Chapter 20 purple photosynthetic sulfur bacteria The Proteobacteria may have arose from a single photosynthetic ancestor 16S rRNA shows five distinct lineages 12-27-2011 12-28-2011 Class α-proteobacteria Most are oligotrophic (growing at low nutrient level) Fig. 20.11 Genus Rhizobium motile rods often contain poly-β- hydroxybutyrate (PHB) granules become pleomorphic under adverse conditions grow symbiotically as nitrogen- fixing bacteroids (Æ ammonium) within root nodule cells of legumes Genus Agrobacterium Figure 20.12 transform infected plant cells (crown, roots, and stems) into autonomously proliferating tumors Agrobacterium tumefaciens causes crown gall disease by means of tumor-inducing (Ti) plasmid Crown gall (冠癭) of a tomato plant Agrobacterium Ti (tumor inducing) plamid Transfer the T-DNA to plant and lower fungi Can also mobilize other plasmid with to plant cells A vector used for transgenic plant Fig. 29.13 Genus Brucella important human and animal pathogen (zoonosis) Brucellosis- undulant fever 波型熱 A select agent as biocrime ingestion of contaminated food (milk products); inhalation, via skin wound, rare person-to-person Acute form: flu-like symptom; undulant form: undulant fever, arthritis, and testicular inflammation, neurologic symptom may occur; chronic form: chronic fatigue, depression, and arthritis Class β-proteobacteria Nitrogen metabolism Nitrifying bacteria- Nitrification oxidation of ammonium to nitrite, nitrite further oxidized to nitrate Nitrobacter (α-proteobacteria) Nitrosomonas (β-proteobacteria) Nitrosococcus (γ-proteobacteria) Nitrogen Fixation Burkholderia and Ralstonia (β-proteobacteria) both form symbiotic associations with legumes both have nodulation genes (nod) a common genetic origin with rhizobia (α-proteobacteria) obtained through lateral gene transfer Order Burkholderiales Burkholderia cepacia degrades > 100 organic molecules very active in recycling organic material plant and human pathogen (nosocomial pathogen) a particular problem for cystic fibrosis patients B. -
Overview: Development in Bacteria: Spore Formation in Bacillus Subtilis
CMLS, Cell. Mol. Life Sci. 59 (2002) 389–391 1420-682X/02/030389-03 $ 1.50 + 0.20/0 © Birkhäuser Verlag, Basel, 2002 CMLS Cellular and Molecular Life Sciences Overview: development in bacteria: spore formation in Bacillus subtilis A. Driks Department of Microbiology and Immunology, Loyola University Medical Center, 2160 South First Avenue, Maywood, Illinois 60153 (USA), Fax +1 708 216 9574, e-mail: [email protected] Abstract. Like eukaryotes, bacteria possess complex de- toplasm coalesce into the various complex structures that velopmental programs that drive environmental adapta- comprise the spore. The resulting cell is metabolically tion and morphological differentiation. In some species, dormant and as close to indestructible as any cell found these morphological changes are quite elaborate and re- on earth. Nonetheless, the spore retains the ability to re- sult in major changes in cell appearance, including the vive almost immediately when nutrient returns to the en- formation of ornate appendages. The ease with which vironment. Here, we review the genetic control of spore some bacteria can be manipulated makes them highly at- formation, the structure and assembly of several major tractive model systems for developmental analysis. In this spore components, the process of germination, and the set of reviews, we tackle the best studied of these systems, environmental and disease implications of spores. As spore formation in Bacillus subtilis. Construction of a these reviews document, spore formation in B. subtilis spore initiates in response to starvation, takes each cell has been among the most productive systems for under- about 8 h and is directed by a tightly controlled genetic standing both the broad themes and the molecular basis program. -
Description of Gabonibacter Massiliensis Gen. Nov., Sp. Nov., a New Member of the Family Porphyromonadaceae Isolated from the Human Gut Microbiota
Curr Microbiol DOI 10.1007/s00284-016-1137-2 Description of Gabonibacter massiliensis gen. nov., sp. nov., a New Member of the Family Porphyromonadaceae Isolated from the Human Gut Microbiota 1,2 1 3,4 Gae¨l Mourembou • Jaishriram Rathored • Jean Bernard Lekana-Douki • 5 1 1 Ange´lique Ndjoyi-Mbiguino • Saber Khelaifia • Catherine Robert • 1 1,6 1 Nicholas Armstrong • Didier Raoult • Pierre-Edouard Fournier Received: 9 June 2016 / Accepted: 8 September 2016 Ó Springer Science+Business Media New York 2016 Abstract The identification of human-associated bacteria Gabonibacter gen. nov. and the new species G. mas- is very important to control infectious diseases. In recent siliensis gen. nov., sp. nov. years, we diversified culture conditions in a strategy named culturomics, and isolated more than 100 new bacterial Keywords Gabonibacter massiliensis Á Taxonogenomics Á species and/or genera. Using this strategy, strain GM7, a Culturomics Á Gabon Á Gut microbiota strictly anaerobic gram-negative bacterium was recently isolated from a stool specimen of a healthy Gabonese Abbreviations patient. It is a motile coccobacillus without catalase and CSUR Collection de Souches de l’Unite´ des oxidase activities. The genome of Gabonibacter mas- Rickettsies siliensis is 3,397,022 bp long with 2880 ORFs and a G?C DSM Deutsche Sammlung von content of 42.09 %. Of the predicted genes, 2,819 are Mikroorganismen protein-coding genes, and 61 are RNAs. Strain GM7 differs MALDI-TOF Matrix-assisted laser desorption/ from the closest genera within the family Porphyromon- MS ionization time-of-flight mass adaceae both genotypically and in shape and motility. -
Impact of the Post-Transplant Period and Lifestyle Diseases on Human Gut Microbiota in Kidney Graft Recipients
microorganisms Article Impact of the Post-Transplant Period and Lifestyle Diseases on Human Gut Microbiota in Kidney Graft Recipients Nessrine Souai 1,2 , Oumaima Zidi 1,2 , Amor Mosbah 1, Imen Kosai 3, Jameleddine El Manaa 3, Naima Bel Mokhtar 4, Elias Asimakis 4 , Panagiota Stathopoulou 4 , Ameur Cherif 1 , George Tsiamis 4 and Soumaya Kouidhi 1,* 1 Laboratory of Biotechnology and Valorisation of Bio-GeoRessources, Higher Institute of Biotechnology of Sidi Thabet, BiotechPole of Sidi Thabet, University of Manouba, Ariana 2020, Tunisia; [email protected] (N.S.); [email protected] (O.Z.); [email protected] (A.M.); [email protected] (A.C.) 2 Department of Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Farhat Hachad Universitary Campus, Rommana 1068, Tunis, Tunisia 3 Unit of Organ Transplant Military Training Hospital, Mont Fleury 1008, Tunis, Tunisia; [email protected] (I.K.); [email protected] (J.E.M.) 4 Laboratory of Systems Microbiology and Applied Genomics, Department of Environmental Engineering, University of Patras, 2 Seferi St, 30100 Agrinio, Greece; [email protected] (N.B.M.); [email protected] (E.A.); [email protected] (P.S.); [email protected] (G.T.) * Correspondence: [email protected]; Tel.: +216-95-694-135 Received: 8 September 2020; Accepted: 30 October 2020; Published: 4 November 2020 Abstract: Gaining long-term graft function and patient life quality remain critical challenges following kidney transplantation. Advances in immunology, gnotobiotics, and culture-independent molecular techniques have provided growing insights into the complex relationship of the microbiome and the host. However, little is known about the over time-shift of the gut microbiota in the context of kidney transplantation and its impact on both graft and health stability. -
W O 2017/079450 Al 11 May 2017 (11.05.2017) W IPOI PCT
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2017/079450 Al 11 May 2017 (11.05.2017) W IPOI PCT (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K35/741 (2015.01) A61K 35/744 (2015.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, A61K 35/745 (2015.01) A61K35/74 (2015.01) DO, DZ, EC, EE, EG, ES, Fl, GB, GD, GE, GH, GM, GT, C12N1/20 (2006.01) A61K 9/48 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, A61K 45/06 (2006.01) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (21) International Application Number: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, PCT/US2016/060353 SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, (22) International Filing Date: TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, 3 November 2016 (03.11.2016) ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated,for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (30) Priority Data: TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, 62/250,277 3 November 2015 (03.11.2015) US TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, Fl, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (71) Applicants: THE BRIGHAM AND WOMEN'S HOS- LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, PITAL [US/US]; 75 Francis Street, Boston, Massachusetts SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, 02115 (US). -
Supplementary Tables and Figures
SUPPLEMENTARY TABLES AND FIGURES Table S1: Isolated microorganisms from three fecal samples from controls on five different media. YCFAG SCH Δ0 ΔV ΔS SCH SCH +AAA +FS +AAA +FS +AAA +FS +FS ACTINOBACTERIA Bifidobacteriaceae Bifidobacterium catenulatum/ N N N N N pseudocatenulatum Bifidobacterium longum N N N N Coriobacteriaceae Collinsella aerofaciens N Corynebacteriaceae Corynebacterium sp. O O O Corynebacterium aurimucosum O O Corynebacterium striatum O O BACTEROIDETES Bacteroideaceae Bacteroides caccae N Bacteroides cellulosilyticus N N Bacteroides fragilis N Bacteroides ovatus N N Bacteroides thetaiotaomicron N Bacteroides uniformis N N Bacteroides vulgatus N N N N Tannerellaceae Parabacteroides distasonis N FIRMICUTES Bacillaceae Bacillus sp. O Bacillus pumilus O O Enterococcaceae Enterococcus faecium O/N O/N O/N O O/N Enterococcus mundtii O O O Erysipelotrichaceae Clostridium innocuum N N Staphylococcaceae Staphylococcus sp. O Staphylococcus parasanguinis O PROTEOBACTERIA Enterobacteriaceae Citrobacter amalonaticus O Escherichia coli O/N O/N O/N O/N O/N EUKARYOTES Candida albicans O TOTAL N° OF DIFFERENT ISOLATES 6/9 6/9 6/7 4/7 5/3 (O/N) YCFAG: Yeast Casitone Fatty Acid Glucose medium; Δ0: medium unchanged; ΔV: medium without vitamins; ΔS: medium without short chain fatty acids; FS: fecal suspension; AAA: aromatic amino acids; SCH: Schaedler medium; O: isolated from fecal samples on corresponding medium after aerobic incubation (37 °C for 2 to 5 days); N: isolated from fecal samples on corresponding medium after anaerobic incubation (37 °C for 5 to 7 days). Table S2: Correlation between the abundance of the bacterial taxa, as assessed by means of qPCR, and estimated glomerular filtration rate (eGFR). -
Intestinal Microbiota: a Novel Target to Improve Anti-Tumor Treatment?
Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? Romain Villeger, Amélie Lopès, Guillaume Carrier, Julie Veziant, Elisabeth Billard, Nicolas Barnich, Johan Gagnière, Emilie Vazeille, Mathilde Bonnet To cite this version: Romain Villeger, Amélie Lopès, Guillaume Carrier, Julie Veziant, Elisabeth Billard, et al.. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?. International Journal of Molecular Sciences, MDPI, 2019, 20 (18), pp.4584. 10.3390/ijms20184584. hal-02518541 HAL Id: hal-02518541 https://hal.archives-ouvertes.fr/hal-02518541 Submitted on 8 Jun 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License International Journal of Molecular Sciences Review Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? 1, , 1,2, 1,3 1,4,5 Romain Villéger * y , Amélie Lopès y , Guillaume Carrier , Julie Veziant , Elisabeth Billard 1 , Nicolas Barnich 1 , Johan Gagnière 1,4,5, Emilie Vazeille 1,5,6 and Mathilde Bonnet 1 1 Microbes,